Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
25.66
+0.33 (1.30%)
At close: May 19, 2026, 4:00 PM EDT
25.62
-0.04 (-0.16%)
After-hours: May 19, 2026, 5:05 PM EDT
Pfizer Stock Forecast
Stock Price Forecast
According to 29 analysts polled by S&P Global, Pfizer stock has a consensus rating of "Buy" and an average price target of $29.19. The average 1-year stock price forecast is 13.76% higher than the current stock price, while the lowest is $24 (-6.47%) and the highest is $36 (+40.30%).
Price Target: $29.19 (+13.76%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Pfizer stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 9 | 10 | 8 | 8 | 7 | 7 |
| Sell | 0 | 0 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Hold Maintains $26 → $27 | Hold | Maintains | $26 → $27 | +5.22% | Apr 29, 2026 |
| RBC Capital | RBC Capital | Sell Reiterates $25 | Sell | Reiterates | $25 | -2.57% | Apr 20, 2026 |
| CICC | CICC | Buy Initiates $33 | Buy | Initiates | $33 | +28.60% | Apr 16, 2026 |
| UBS | UBS | Hold Maintains $25 → $27 | Hold | Maintains | $25 → $27 | +5.22% | Apr 13, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $27 → $28 | Hold | Maintains | $27 → $28 | +9.12% | Apr 10, 2026 |
Financial Forecast
Revenue This Year
62.03B
from 62.58B
Decreased by -0.87%
Revenue Next Year
59.61B
from 62.03B
Decreased by -3.90%
EPS This Year
2.99
from 1.36
Increased by 119.39%
EPS Next Year
2.84
from 2.99
Decreased by -4.97%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 65.7B | 66.7B | ||||||
| Avg | 62.0B | 59.6B | ||||||
| Low | 59.0B | 54.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 4.9% | 7.5% | ||||||
| Avg | -0.9% | -3.9% | ||||||
| Low | -5.6% | -11.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 3.28 | 3.25 | ||||||
| Avg | 2.99 | 2.84 | ||||||
| Low | 2.74 | 2.41 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 140.1% | 8.5% | ||||||
| Avg | 119.4% | -5.0% | ||||||
| Low | 101.1% | -19.5% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.